Evidence for the major contribution of remodeling-based bone formation in sclerostin-deficient mice

• Published in: Bone (New York, N.Y.) Vol. 160; p. 116401
• Main Authors: Koide, Masanori, Yamashita, Teruhito, Nakamura, Keigo, Yasuda, Hisataka, Udagawa, Nobuyuki, Kobayashi, Yasuhiro
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.07.2022
• Subjects: Antiresorptive agent; Bone formation; Bone modeling and remodeling; Bone resorption; Sclerostin; Bone resorption; Bone modeling and remodeling; RBBF; RANKL; Bone formation; PTH; OPG; Antiresorptive agent; Sclerostin; MBBF
• ISSN: 8756-3282; 1873-2763
• DOI: 10.1016/j.bone.2022.116401

Bone formation by osteoblasts is achieved through remodeling-based bone formation (RBBF) and modeling-based bone formation (MBBF). The former is when bone formation occurs after osteoclastic bone resorption to maintain bone mass and calcium homeostasis. The latter is when new bone matrices are added on the quiescent bone surfaces. Administration of anti-sclerostin neutralizing antibody promotes MBBF in ovariectomized rats and postmenopausal women. However, it remains to be elucidated which mode of bone formation mainly occurs in Sost-deficient mice under physiological conditions. Here, we show that two-thirds of bone formation involves RBBF in 12-week-old Sost-deficient mice (C57BL/6 background). Micro-computed tomography and histomorphometric analyses showed that the trabecular bone mass in Sost-KO mice was higher than that in Sost+/− mice. In contrast, the osteoclast number remained unchanged in Sost-KO mice, but the bone resorption marker TRAP5b in serum was slightly higher in those mice. Treatment with anti-RANKL antibody increased the trabecular bone mass of Sost+/− or Sost-KO mice. Bone formation markers such as osteoid surfaces, the mineral apposition rate, and bone formation rate were almost completely suppressed in Sost+/− mice treated with anti-RANKL antibody compared with vehicle-treated Sost+/− mice. In Sost-KO mice, treatment with anti-RANKL antibody suppressed those parameters by more than half. These findings indicate that RBBF accounts for most of the bone formation in Sost+/− mice, whereas approximately two-thirds of bone formation is estimated to be remodeling-based in 12-week-old Sost-deficient mice. Furthermore, anti-RANKL antibody may be useful for detecting MBBF on trabecular bone. •Modeling-based bone formation is present in Sost-KO mice although it contributes less than remodeling-based bone formation.•Bone formation in Sost-KO mice is largely dependent on bone resorption.•Injection of anti-RANKL Abs to Sost+/- mice suppressed bone resorption and subsequent completely suppressed bone formation.•Injection of anti-RANKL Abs to Sost-KO mice subsequent suppressed bone formation by more than half.